Valuation: Medicure Inc.

Market Cap 13.46M 9.49M 8.33M 7.69M 7.1M 909M 13.73M 92.4M 35.9M 445M 35.65M 34.86M 1.54B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.52M 7.42M 6.5M 6.01M 5.55M 710M 10.73M 72.2M 28.05M 348M 27.85M 27.24M 1.21B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.78%
1 month+24.04%
3 months+5.74%
6 months+3.20%
Current year+13.16%
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO - 31/05/2022
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 92 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-21Buy

Chief Executive Officer

1,000 0.0096%
06-21Buy

Chief Executive Officer

200 0.0019%
06-21Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-.--%+4.88%+12.17% 9.49M
-1.53%+0.78%+72.33%+129.70% 57.72B
-2.45%-7.83%+63.92%+83.15% 52.65B
+3.27%+8.91%+21.21%+486.76% 24.46B
-0.81%-0.42%-16.24%-12.47% 23.84B
+4.99%+4.18%+44.25%-1.68% 19.28B
-0.24%+5.11%+38.76%-26.41% 17.8B
+2.34%+12.50%+224.02%+380.99% 17.29B
-1.17%+1.33%+35.45% - 15.28B
-1.70%+3.98%+28.96%+190.57% 14.35B
Average +0.33%+5.28%+51.75%+138.09% 24.27B
Weighted average by Cap. -0.29%+3.12%+57.87%+141.99%

Financials

2024 2025
Net sales 21.91M 15.45M 13.55M 12.51M 11.56M 1.48B 22.35M 150M 58.42M 724M 58M 56.73M 2.51B 28.86M 20.34M 17.84M 16.47M 15.22M 1.95B 29.43M 198M 76.95M 953M 76.4M 74.73M 3.31B
Net income -1.04M -733K -643K -593K -548K -70.14M -1.06M -7.13M -2.77M -34.33M -2.75M -2.69M -119M -7.1M -5M -4.39M -4.05M -3.74M -479M -7.24M -48.71M -18.93M -234M -18.79M -18.38M -814M
Net Debt -6.32M -4.45M -3.91M -3.61M -3.33M -426M -6.44M -43.36M -16.85M -209M -16.73M -16.36M -724M -2.94M -2.08M -1.82M -1.68M -1.55M -199M -3M -20.21M -7.85M -97.26M -7.79M -7.62M -338M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume